Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
All News
Headline News
Barchart.com
Benzinga
BreakingCrypto
Chartmill
Finterra
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
MarketMinute
PredictStreet
StockStory
Stocktwits
Talk Markets
TokenRing AI
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Actusnews Wire
Authority Press Wire
Binary News Network
Brandpoint
BusinesNews Wire
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
eTrendy Stock
FinancialNewsMedia
First Publisher
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
NewMediaWire
Newsfile
NewsUSA
Newswire.com
PR Underground
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
PulseBulletin.com
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
TheNewswire
Visibility
Worldnewswire
Zexprwire
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Ero Announces Inaugural PEA for Furnas, Outlines Low Capital Intensity Project with a 24-Year Initial Mine Life
February 23, 2026
From
Ero Copper Corp.
Via
GlobeNewswire
Tickers
ERO
TSX:ERO
AMC Networks Announces Any and All Exchange Offer and Consent Solicitation for its 10.25% Senior Secured Notes due 2029
February 23, 2026
From
AMC Networks Inc.
Via
GlobeNewswire
Tickers
AMCX
AMC Networks Announces Effectiveness of Amendments to its 10.50% Senior Secured Notes due 2032 and Extension of Consent Solicitation
February 23, 2026
From
AMC Networks Inc.
Via
GlobeNewswire
Tickers
AMCX
Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations
February 23, 2026
From
Palvella Therapeutics Inc.
Via
GlobeNewswire
Tickers
PVLA
OCI Energy and Arava Power have closed construction financing with ING Capital to support a 347 MWdc solar energy project near Houston
February 23, 2026
From
OCI Energy
Via
GlobeNewswire
From Capitol Hill to the Cays: The Bahamas Brings “A Lifetime of Islands” to Washington, D.C.
February 23, 2026
From
The Bahamas Ministry of Tourism
Via
GlobeNewswire
Calian Appoints Will Majic as Acting Chief Financial Officer
February 23, 2026
From
Calian Group Ltd.
Via
GlobeNewswire
Tickers
TSX:CGY
NJDCY Announcement: If You Have Suffered Losses in Nidec Corporation (OTC: NJDCY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
February 23, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
Tickers
NJDCY
Smith+Nephew signs distribution agreement with SI-BONE
February 23, 2026
From
Smith & Nephew UK Ltd
Via
GlobeNewswire
Tickers
SNN
Ultragenyx to Participate at Investor Conferences in March
February 23, 2026
From
Ultragenyx Pharmaceutical Inc.
Via
GlobeNewswire
Tickers
RARE
DHT Holdings, Inc. secures one-year time charter for DHT Redwood
February 23, 2026
From
DHT Holdings, Inc.
Via
GlobeNewswire
Tickers
DHT
ONEOK Announces Higher Full-Year 2025 Earnings: Net Income up 11%, Adjusted EBITDA up 18%
February 23, 2026
From
ONEOK, Inc.
Via
GlobeNewswire
Tickers
OKE
FinWise Bancorp Announces Agreement with Albert Corporation to Offer Millions of Americans Transparent, Affordable and Convenient Short-term Personal Loans
February 23, 2026
From
FinWise Bank
Via
GlobeNewswire
Tickers
FINW
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
February 23, 2026
From
AVITA Medical
Via
GlobeNewswire
Tickers
ASX:AVH
RCEL
Silo Pharma Announces Share Buyback Program
February 23, 2026
From
Silo Pharma, Inc.
Via
GlobeNewswire
Tickers
SILO
European Wax Center, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4th
February 23, 2026
From
European Wax Center, Inc.
Via
GlobeNewswire
Tickers
EWCZ
General Fusion to Highlight Commercialization Path and Capital Markets Strategy at Upcoming Global Fusion Industry and Investor Conferences
February 23, 2026
From
General Fusion
Via
GlobeNewswire
Tickers
SMR
SVAC
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
February 23, 2026
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RLAY
Great Lakes Reports Fourth Quarter and Full Year 2025 Results and the Signing of Two International Offshore Energy Contracts
February 23, 2026
From
Great Lakes Dredge & Dock Corporation
Via
GlobeNewswire
Tickers
GLDD
Phillips Edison & Company to Present at Citi’s 2026 Global Property CEO Conference
February 23, 2026
From
Phillips Edison & Company, Inc.
Via
GlobeNewswire
Tickers
PECO
ROC Announces Closing of Upsized Initial Public Offering
February 23, 2026
From
ROC
Via
GlobeNewswire
Tickers
ROC
Sana Biotechnology to Present at March 2026 Investor Conferences
February 23, 2026
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Tickers
SANA
MediaAlpha Announces Fourth Quarter and Full Year 2025 Financial Results
February 23, 2026
From
MediaAlpha, Inc.
Via
GlobeNewswire
Tickers
MAX
Olaplex Holdings, Inc. to Report Fourth Quarter and Fiscal 2025 Financial Results on March 5th
February 23, 2026
From
Olaplex Holdings, Inc.
Via
GlobeNewswire
Tickers
OLPX
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements
February 23, 2026
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tickers
TARS
EverQuote Announces Fourth Quarter and Full Year 2025 Financial Results
February 23, 2026
From
EverQuote, Inc.
Via
GlobeNewswire
Tickers
EVER
Adeia Announces Record Fourth Quarter and Full Year 2025 Financial Results
February 23, 2026
From
Adeia Inc.
Via
GlobeNewswire
Tickers
ADEA
Remitly Announces Upcoming Webinar and Investor Conference Participation
February 23, 2026
From
Remitly, Inc.
Via
GlobeNewswire
Tickers
RELY
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
February 23, 2026
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Tickers
MYGN
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
February 23, 2026
From
ORIC Pharmaceuticals
Via
GlobeNewswire
Tickers
ORIC
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.